SuperDial vs Amperos: AI Voice Agents for Dental Payer Calls Compared

Two Platforms. Two Very Different Problems.

If you search for dental AI payer call automation, SuperDial and Amperos both come up. Both raised significant venture funding. Both are targeting the dental revenue cycle. A surface-level comparison might lead you to put them head-to-head as direct competitors.

They're not. They solve different problems, and buying the wrong one — or comparing them on the wrong criteria — will leave you frustrated regardless of which you choose.

Here's the precise distinction:

SuperDial automates the outbound phone calls your billing team makes to insurance companies. That's it. When your biller needs to call Delta Dental to check a claim status, verify eligibility, or get a reference number, SuperDial places that call and navigates the IVR. It's a phone call automation tool applied to payer interactions.

Amperos is a denial management platform that operates autonomously across multiple channels — payer portals, phone lines, and appeals generation — to resolve denied claims from initiation to payment. SuperDial makes the call. Amperos works the entire denial until it closes.

That's the 30-second version. Now let's go deep on both, because the implications for your practice are significant.

---

SuperDial: The Detailed Picture

What It Actually Does

SuperDial was founded to solve a specific and well-documented problem: dental billing teams spend a significant portion of their day on hold with insurance companies. Industry estimates vary, but most dental billers report spending 30–60 minutes per day on payer phone calls. At a 5-doctor practice with 2 dedicated billing staff, that's potentially 1–2 hours of labor per day just navigating IVRs and waiting.

SuperDial places those calls on behalf of your billers. The AI navigates the payer's phone system, selects the right menu options, handles hold times, and either extracts the information needed (claim status, eligibility data, reference numbers) or — for more complex calls — bridges your team member into the call at the right moment to speak with a human representative.

The result: your biller submits a call request, SuperDial handles the IVR navigation and hold time in the background, and your biller gets pinged when there's a human on the line or when the automated response has been captured.

Carrier Coverage

SuperDial supports 600+ insurance carriers for automated call handling. The top tier — Delta Dental, Cigna, MetLife, Aetna, United Concordia, Humana, Guardian, Principal — are fully automated with no human bridge required for routine inquiries. For smaller regional carriers, the automation depth varies.

What SuperDial Does NOT Do

This is the critical distinction that sales calls tend to gloss over.

• Interpret the information it retrieves
• Identify the root cause of a denial
• Write an appeal letter
• Submit corrected claims
• Track denial patterns across your payer mix
• Close a denied claim autonomously

When SuperDial calls Delta Dental and hears "claim denied for missing information," it captures that response and delivers it to your biller. What happens next is entirely human. The biller reads the denial reason, decides on the appeal strategy, writes the appeal or corrected claim, and submits it.

SuperDial is a labor efficiency tool. It eliminates hold time. It does not eliminate the work.

ROI Math for SuperDial

Let's be specific. At a practice where your billing team makes 15 payer calls per day (a conservative number for a 4–5 doctor practice):

• Average hold time per call: 12–18 minutes
• Average IVR navigation time: 3–5 minutes
• Total phone time per day: 225–345 minutes (3.75–5.75 hours)

With SuperDial handling IVR navigation and hold time, that same work takes 30–60 minutes of biller attention (submitting requests, reviewing results, handling bridged calls). The recovered time — 3+ hours per day — represents:

• At $20/hour biller cost: $60/day, $1,320/month
• At $25/hour: $75/day, $1,650/month

SuperDial's pricing isn't public, but practitioners report costs in the $400–$800/month range for mid-size practices. The math works if your payer call volume is high enough.

The break-even question: Are you making enough payer calls to justify the monthly fee? If your billing team is making fewer than 5–8 payer calls per day, the ROI case weakens.

Who SuperDial Is For

• Practices with dedicated billing staff spending significant daily time on payer calls
• Billing service companies managing 10+ practices
• Multi-location groups where billing is centralized
• Practices with high claim submission volume relative to their biller headcount

• Solo practices where the front desk handles billing part-time
• Practices that have already moved most payer interactions to portal-based workflows
• Practices whose primary problem is denial rate, not billing staff efficiency

---

Amperos: The Detailed Picture

What It Actually Does

Amperos is building something more ambitious: an autonomous denial management system that works claims from initial denial through to payment or final appeal, without requiring your staff to drive the process.

1. Identifies the denial reason and categorizes it (clinical, administrative, timely filing, eligibility, etc.)
2. Determines the correct remediation path for that denial category
3. Executes that path autonomously — which might mean submitting a corrected claim, working a payer portal, placing a phone call, or generating an appeal with supporting documentation
4. Tracks the claim through subsequent adjudication
5. Escalates to a human only when the autonomous path has been exhausted or a clinical judgment is required

The phone call capability in Amperos is one channel among several. When a denial requires a payer call to resolve, Amperos places it. But Amperos is equally capable of working through payer portals, submitting electronic appeals, or generating appeal letters — routing each denial to the most efficient resolution channel.

The $16M Series A Signal

Amperos raised a $16M Series A in 2025. That's meaningful context for buyers. The capital is funding two things: expansion of their autonomous portal integration library (they need to work within each payer's web interface without being blocked) and training data for their clinical appeal generation model.

The portal integration piece is genuinely hard technical work. Payer portals were not designed to be automated — they have CAPTCHA challenges, frequent UI changes, and session management that fights automation. Amperos has built proprietary technology to operate within these portals at scale, and the Series A is largely maintaining and expanding that infrastructure.

Where Amperos Adds the Most Value

Denial management is one of the highest-ROI areas in dental revenue cycle because the problem is so well-quantified. The average dental practice has a denial rate of 5–12%. Of those denials, 60–70% are ultimately recoverable with appropriate follow-up. The gap between what gets denied and what gets recovered is almost entirely a function of whether your team has capacity to work every denial.

Most practices don't. Denied claims that require more than one follow-up action frequently age out — either past timely filing limits or past the point where your team treats the account as a loss. Amperos attacks that problem with autonomous persistence: the system works every denial regardless of complexity, without fatigue.

ROI math at scale:
Practice collecting $2M annually, 8% denial rate = $160K in denied claims/year.
Industry average recovery rate with manual processes: 55–65% of denials = $88K–$104K recovered.
With autonomous denial management targeting 85%+ recovery: $136K recovered.
The gap: $32K–$48K in additional annual collections.

That delta is real and it's why denial management AI has attracted the most institutional investment in dental RCM.

What Amperos Does NOT Do

Amperos is not a verification platform. It doesn't prevent denials at the front end by running better eligibility checks. If your denial problem is upstream — patients being scheduled with incorrect benefit assumptions, wrong procedure codes, missing clinical documentation at the time of service — Amperos won't fix those. It resolves denials after they happen; it doesn't prevent the errors that cause them.

This is a critical strategic point. The best dental RCM stack addresses both ends: prevention (verification, pre-auth, clinical documentation at time of service) and resolution (denial management, appeals automation). Amperos is resolution-focused.

Who Amperos Is For

• Practices with high denial volume (8%+ denial rate, or $50K+ in outstanding denied claims)
• Mid-size groups and DSOs where denial follow-up falls through the cracks due to billing capacity
• Practices with aging denial queues — claims that have been denied 60–90+ days ago and haven't been worked
• Billing service companies managing denial resolution across multiple practices

• Practices with very low denial rates (<4%) maintained by strong front-end processes
• Solo practices where one biller handles the full cycle and denial rates are already under control
• Practices whose primary problem is front-end: eligibility errors, pre-auth failures, coding mistakes

---

The Real Comparison: When You Might Need Both

The question shouldn't be "SuperDial or Amperos?" for most practices. The question should be: what's my primary constraint in the revenue cycle?

Primary constraint: biller time on phone calls → Start with SuperDial

If your billers are productive and skilled but spending too much time on hold, SuperDial gives them those hours back. They can work more denials, more accounts, more efficiently.

Primary constraint: denial rate and recovery → Start with Amperos

If your denial rate is high and your team isn't recovering enough of what gets denied, the problem isn't phone call efficiency — it's denial management capacity. Amperos attacks that directly.

Both problems exist → Evaluate both in parallel, prioritize by dollar value

• Phone time inefficiency cost = daily hold time × hourly biller cost × 250 working days
• Unrecovered denial cost = denial volume × unrecovered rate × average claim value

Whichever number is larger is where you start.

---

Pricing Reality

Neither platform publishes pricing, which is frustrating.

SuperDial: Practitioner reports suggest $400–$900/month for a typical dental practice, with pricing likely tied to call volume. Some reports of per-call pricing models for lower-volume users.

Amperos: Series A company pricing is in active evolution. Early implementations reportedly ranged from $800–$2,000/month, with performance-based components (percentage of recovered denials) in some contracts. Verify current pricing directly — this is changing.

Both platforms have a clear incentive to structure pricing around value delivered. Amperos's performance component (if they offer it in your contract) is actually a strong alignment signal — they only win if you win on recoveries.

---

The Integration Question

Both platforms require PMS access to function. Ask specifically:

SuperDial: What PMS integrations are available? How does call data get back into the patient account? Does call history sync to the claim?

Amperos: Which PMS platforms does the denial routing read from? How does the system update the account when a denial is resolved? Can it create adjustment entries automatically?

For both: what happens when a carrier changes their phone system or portal? What's your update cycle, and what do we experience during the gap?

---

The Vendor Stability Question

Both SuperDial and Amperos are VC-backed startups. SuperDial has raised approximately $15M. Amperos closed a $16M Series A. Neither has disclosed revenue, and neither has been around long enough to prove long-term sustainability.

• Who are your current dental group customers I can speak with?
• What's your current customer count?
• What's your customer retention rate after year one?
• What happens to our data and workflow if you're acquired or shut down?

Avized maintains independent vendor profiles for both SuperDial and Amperos, including funding history, customer footprint, and practitioner-reported experience. Review those before beginning a sales process with either company.

---

Bottom Line

SuperDial makes your billing team more efficient at phone-based payer interactions. Amperos makes your denial resolution process autonomous and more thorough. They are complementary tools solving adjacent problems.

If you're choosing between them with a limited budget: quantify the dollar value of each problem. The bigger number wins the budget. Most practices with significant denial backlogs will find the Amperos ROI case is larger. Most high-volume practices where billing team efficiency is the bottleneck will find SuperDial's case is clearer.

Either way, neither platform replaces a strong front-end revenue cycle process. Getting verifications right, coding correctly, and submitting clean claims reduces the work that both of these platforms are designed to handle.